Market Overview:
The global pantoprazole sodium market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of gastrointestinal (GI) disorders, rising geriatric population, and growing demand for proton pump inhibitors (PPIs). Based on type, the global pantoprazole sodium market is segmented into delayed-release tablets, injection, and enteric-coated capsules. The delayed-release tablets segment is expected to account for the largest share of the global pantoprazole sodium market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The large share of this segment can be attributed to its high usage rates and growing demand for long-acting formulations. Based on application, the global pantoprazole sodium market is divided into gastroenterology and hepatology (liver, pancreatic & gall bladder diseases). The gastroenterology application segment accounted for majority share of the overall Pantoprazole Sodium Market in 2017 owing higher usage rates across various geographies due Gastroesophageal Reflux Disease (GERD), peptic ulcer disease etc., followed by hepatology applications such as liver cirrhosis etc.
Product Definition:
Pantoprazole Sodium is a proton pump inhibitor that suppresses gastric acid secretion. It is used to treat gastroesophageal reflux disease, duodenal ulcers, and Zollinger-Ellison syndrome.
Delayed-Release Tablets:
Delayed-release tablets are a formulation that releases the active ingredient over an extended period of time. The drug is released in two or more portions, at times separated by weeks and months, depending on the formulation. Delayed-release formulations are used for treating conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome (ZES).
Injection:
Injection is a medical procedure wherein the active ingredient is introduced into the patient's body. The drug or medication that is to be administered must first be extracted from its original form and then formulated in an appropriate vehicle, which may vary according to requirements. Injection allows for ease of administration and improved patient compliance as compared to oral medications; this factor has been contributing largely towards its increasing usage over the years.
Application Insights:
Gastroenterology held the largest share of over 50.0% in 2017 in terms of revenue. Pantoprazole sodium is used for the treatment of various disorders pertaining to the gastrointestinal tract, such as heartburn, indigestion, nausea and abdominal pain. These symptoms are often associated with a diagnosis of gastroesophageal reflux disease (GERD).
The prevalence rate for GERD has increased significantly over the past few years and is estimated to increase further due to rising global awareness about this disease coupled with increasing cases of unhealthy lifestyle habits such as improper diet and excessive drinking alcohol consumption that can trigger acid reflux or heartburn. This factor will boost demand for pantoprazole sodium tablets & capsules during forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period owing to increasing prevalence of Helicobacter pylori infection, rising incidence of ulcer diseases and reflux esophagitis, and presence of well-established healthcare facilities in North America. In addition, high adoption rate for novel therapeutics is also driving the regional market growth.
Asia Pacific pantoprazole sodium market is anticipated to grow at a significant rate during the forecast period due to presence or emerging economies such as China & India with large patient pool & favorable government initiatives for improving public health are expected drive this regional growth over next eight years (2018 - 2030). Moreover, growing awareness about various treatment options available along with increasing disposable income will also support regional growth during same period.
Growth Factors:
- Increasing prevalence of gastrointestinal diseases: The increasing prevalence of gastrointestinal diseases is one of the major growth drivers for the pantoprazole sodium market. According to a study by the World Gastroenterology Organisation, approximately 15%–25% of the global population suffers from some form of gastrointestinal disease. This number is expected to increase in the coming years due to changing lifestyles and dietary habits.
- Rising geriatric population: The geriatric population is another key driver for the pantoprazole sodium market. As people age, their risk for developing various gastrointestinal disorders increases significantly. This growing segment represents a significant opportunity for players in this market as they look to tap into this high-growth demographic.
- Growing awareness about gastroesophageal reflux disease (GERD): GERD is a common disorder that affects millions of people worldwide each year and can cause severe health complications if left untreated. There has been an increasing awareness about this condition in recent years, which has led more people to seek treatment options such as pantoprazole sodium tablets/injection therapy .
Scope Of The Report
Report Attributes
Report Details
Report Title
Pantoprazole Sodium Market Research Report
By Type
Delayed-Release Tablets, Injection, Enteric-Coated Capsules
By Application
Gastroenterology, Hepatology(Liver, Pancreatic, Gall Bladder)
By Companies
Pfizer, Dr Reddy's Laboratories, Takeda GmbH, Teva Pharmaceutical, Lee Pharma Ltd., Luye Pharma Group, Hubei Weisen Pharmaceutical, Liaoning Nirvana Pharmaceutical, Mreeo Pharmaceutical, Shandong Renhetang Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Pantoprazole Sodium Market Report Segments:
The global Pantoprazole Sodium market is segmented on the basis of:
Types
Delayed-Release Tablets, Injection, Enteric-Coated Capsules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gastroenterology, Hepatology(Liver, Pancreatic, Gall Bladder)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Dr Reddy's Laboratories
- Takeda GmbH
- Teva Pharmaceutical
- Lee Pharma Ltd.
- Luye Pharma Group
- Hubei Weisen Pharmaceutical
- Liaoning Nirvana Pharmaceutical
- Mreeo Pharmaceutical
- Shandong Renhetang Pharmaceutical
Highlights of The Pantoprazole Sodium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Delayed-Release Tablets
- Injection
- Enteric-Coated Capsules
- By Application:
- Gastroenterology
- Hepatology(Liver, Pancreatic, Gall Bladder)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pantoprazole Sodium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pantoprazole sodium is a proton pump inhibitor (PPI) that is used to treat gastroesophageal reflux disease (GERD). Pantoprazole helps to reduce the amount of acid that flows up from the stomach and into the esophagus. This can help to relieve symptoms such as heartburn, regurgitation, and difficulty swallowing. Pantoprazole is also used in combination with other medications to treat GERD.
Some of the major companies in the pantoprazole sodium market are Pfizer, Dr Reddy's Laboratories, Takeda GmbH, Teva Pharmaceutical, Lee Pharma Ltd., Luye Pharma Group, Hubei Weisen Pharmaceutical, Liaoning Nirvana Pharmaceutical, Mreeo Pharmaceutical, Shandong Renhetang Pharmaceutical.
The pantoprazole sodium market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pantoprazole Sodium Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pantoprazole Sodium Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pantoprazole Sodium Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pantoprazole Sodium Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pantoprazole Sodium Market Size & Forecast, 2018-2028
4.5.1 Pantoprazole Sodium Market Size and Y-o-Y Growth
4.5.2 Pantoprazole Sodium Market Absolute $ Opportunity
Chapter 5 Global Pantoprazole Sodium Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pantoprazole Sodium Market Size Forecast by Type
5.2.1 Delayed-Release Tablets
5.2.2 Injection
5.2.3 Enteric-Coated Capsules
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pantoprazole Sodium Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pantoprazole Sodium Market Size Forecast by Applications
6.2.1 Gastroenterology
6.2.2 Hepatology(Liver
6.2.3 Pancreatic
6.2.4 Gall Bladder)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pantoprazole Sodium Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pantoprazole Sodium Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pantoprazole Sodium Analysis and Forecast
9.1 Introduction
9.2 North America Pantoprazole Sodium Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pantoprazole Sodium Market Size Forecast by Type
9.6.1 Delayed-Release Tablets
9.6.2 Injection
9.6.3 Enteric-Coated Capsules
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pantoprazole Sodium Market Size Forecast by Applications
9.10.1 Gastroenterology
9.10.2 Hepatology(Liver
9.10.3 Pancreatic
9.10.4 Gall Bladder)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pantoprazole Sodium Analysis and Forecast
10.1 Introduction
10.2 Europe Pantoprazole Sodium Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pantoprazole Sodium Market Size Forecast by Type
10.6.1 Delayed-Release Tablets
10.6.2 Injection
10.6.3 Enteric-Coated Capsules
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pantoprazole Sodium Market Size Forecast by Applications
10.10.1 Gastroenterology
10.10.2 Hepatology(Liver
10.10.3 Pancreatic
10.10.4 Gall Bladder)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pantoprazole Sodium Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pantoprazole Sodium Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pantoprazole Sodium Market Size Forecast by Type
11.6.1 Delayed-Release Tablets
11.6.2 Injection
11.6.3 Enteric-Coated Capsules
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pantoprazole Sodium Market Size Forecast by Applications
11.10.1 Gastroenterology
11.10.2 Hepatology(Liver
11.10.3 Pancreatic
11.10.4 Gall Bladder)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pantoprazole Sodium Analysis and Forecast
12.1 Introduction
12.2 Latin America Pantoprazole Sodium Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pantoprazole Sodium Market Size Forecast by Type
12.6.1 Delayed-Release Tablets
12.6.2 Injection
12.6.3 Enteric-Coated Capsules
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pantoprazole Sodium Market Size Forecast by Applications
12.10.1 Gastroenterology
12.10.2 Hepatology(Liver
12.10.3 Pancreatic
12.10.4 Gall Bladder)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pantoprazole Sodium Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pantoprazole Sodium Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pantoprazole Sodium Market Size Forecast by Type
13.6.1 Delayed-Release Tablets
13.6.2 Injection
13.6.3 Enteric-Coated Capsules
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pantoprazole Sodium Market Size Forecast by Applications
13.10.1 Gastroenterology
13.10.2 Hepatology(Liver
13.10.3 Pancreatic
13.10.4 Gall Bladder)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pantoprazole Sodium Market: Competitive Dashboard
14.2 Global Pantoprazole Sodium Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Dr Reddy's Laboratories
14.3.3 Takeda GmbH
14.3.4 Teva Pharmaceutical
14.3.5 Lee Pharma Ltd.
14.3.6 Luye Pharma Group
14.3.7 Hubei Weisen Pharmaceutical
14.3.8 Liaoning Nirvana Pharmaceutical
14.3.9 Mreeo Pharmaceutical
14.3.10 Shandong Renhetang Pharmaceutical
